CN103520572A - 一种用于治疗特应性皮炎的中药组合物及其制备方法 - Google Patents
一种用于治疗特应性皮炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103520572A CN103520572A CN201310491169.7A CN201310491169A CN103520572A CN 103520572 A CN103520572 A CN 103520572A CN 201310491169 A CN201310491169 A CN 201310491169A CN 103520572 A CN103520572 A CN 103520572A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- heat
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000008937 atopic dermatitis Diseases 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 206010012438 Dermatitis atopic Diseases 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 102
- 229940079593 drug Drugs 0.000 claims abstract description 24
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 15
- 241001407408 Berberis fortunei Species 0.000 claims abstract description 11
- 241000012040 Dickinsia hydrocotyloides Species 0.000 claims abstract description 11
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 32
- 241000628997 Flos Species 0.000 claims description 25
- 238000010438 heat treatment Methods 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 241001649190 Campsis Species 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 241000545442 Radix Species 0.000 claims description 13
- 239000000865 liniment Substances 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 11
- 229940040145 liniment Drugs 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 7
- 241000605447 Anemarrhena Species 0.000 claims description 6
- 241001180876 Saposhnikovia Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 235000011837 pasties Nutrition 0.000 claims description 6
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- -1 sublimed preparation Substances 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 229940099259 vaseline Drugs 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- 241000792859 Enema Species 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000007920 enema Substances 0.000 claims description 2
- 229940095399 enema Drugs 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 241000581682 Sanguisorba Species 0.000 claims 3
- 239000006196 drop Substances 0.000 claims 1
- 239000012567 medical material Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 126
- 239000008280 blood Substances 0.000 abstract description 126
- 230000000694 effects Effects 0.000 abstract description 74
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 9
- 230000002588 toxic effect Effects 0.000 abstract description 9
- 208000015181 infectious disease Diseases 0.000 abstract description 7
- 244000173853 Sanguisorba officinalis Species 0.000 abstract description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 2
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- 241001633574 Adenophora stricta Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000189799 Asimina triloba Species 0.000 abstract 1
- 235000006264 Asimina triloba Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241001546929 Campsis grandiflora Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000004370 Pastinaca sativa Species 0.000 abstract 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000294611 Punica granatum Species 0.000 abstract 1
- 235000014360 Punica granatum Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241001146210 Senecio scandens Species 0.000 abstract 1
- 241000157373 Uncaria rhynchophylla Species 0.000 abstract 1
- 241000159213 Zygophyllaceae Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 235000009165 saligot Nutrition 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 description 80
- 208000002193 Pain Diseases 0.000 description 52
- 230000036407 pain Effects 0.000 description 52
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 47
- 210000000952 spleen Anatomy 0.000 description 45
- 201000010099 disease Diseases 0.000 description 42
- 230000007812 deficiency Effects 0.000 description 40
- 206010011224 Cough Diseases 0.000 description 39
- 230000001737 promoting effect Effects 0.000 description 37
- 210000003734 kidney Anatomy 0.000 description 32
- 210000004072 lung Anatomy 0.000 description 32
- 201000004624 Dermatitis Diseases 0.000 description 31
- 230000001717 pathogenic effect Effects 0.000 description 30
- 208000001848 dysentery Diseases 0.000 description 27
- 210000002784 stomach Anatomy 0.000 description 27
- 241000411851 herbal medicine Species 0.000 description 26
- 208000010668 atopic eczema Diseases 0.000 description 24
- 210000004185 liver Anatomy 0.000 description 23
- 206010012735 Diarrhoea Diseases 0.000 description 22
- 230000008961 swelling Effects 0.000 description 22
- 206010007247 Carbuncle Diseases 0.000 description 21
- 206010037660 Pyrexia Diseases 0.000 description 19
- 210000001124 body fluid Anatomy 0.000 description 19
- 239000010839 body fluid Substances 0.000 description 19
- 210000003205 muscle Anatomy 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 208000006820 Arthralgia Diseases 0.000 description 18
- 206010040882 skin lesion Diseases 0.000 description 18
- 231100000444 skin lesion Toxicity 0.000 description 18
- 230000035922 thirst Effects 0.000 description 18
- 206010042674 Swelling Diseases 0.000 description 17
- 230000017531 blood circulation Effects 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 17
- 231100000614 poison Toxicity 0.000 description 17
- 208000024891 symptom Diseases 0.000 description 17
- 206010030113 Oedema Diseases 0.000 description 16
- 230000001684 chronic effect Effects 0.000 description 16
- 244000052769 pathogen Species 0.000 description 16
- 206010047700 Vomiting Diseases 0.000 description 15
- 208000015220 Febrile disease Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 230000008673 vomiting Effects 0.000 description 14
- 201000000736 Amenorrhea Diseases 0.000 description 13
- 206010001928 Amenorrhoea Diseases 0.000 description 13
- 206010019233 Headaches Diseases 0.000 description 13
- 239000009636 Huang Qi Substances 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 231100000540 amenorrhea Toxicity 0.000 description 13
- 231100000869 headache Toxicity 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 13
- 230000001105 regulatory effect Effects 0.000 description 13
- 206010027514 Metrorrhagia Diseases 0.000 description 12
- 206010063409 Acarodermatitis Diseases 0.000 description 11
- 206010010774 Constipation Diseases 0.000 description 11
- 241000447727 Scabies Species 0.000 description 11
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 11
- 208000033809 Suppuration Diseases 0.000 description 11
- 210000000481 breast Anatomy 0.000 description 11
- 206010013990 dysuria Diseases 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- 210000000936 intestine Anatomy 0.000 description 11
- 208000005687 scabies Diseases 0.000 description 11
- 206010040872 skin infection Diseases 0.000 description 11
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 10
- 208000006673 asthma Diseases 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 210000002683 foot Anatomy 0.000 description 10
- 208000035861 hematochezia Diseases 0.000 description 10
- 208000026435 phlegm Diseases 0.000 description 10
- 210000004915 pus Anatomy 0.000 description 10
- 230000007958 sleep Effects 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 206010000087 Abdominal pain upper Diseases 0.000 description 9
- 208000005171 Dysmenorrhea Diseases 0.000 description 9
- 206010013935 Dysmenorrhoea Diseases 0.000 description 9
- 206010017553 Furuncle Diseases 0.000 description 9
- 206010040943 Skin Ulcer Diseases 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 9
- 230000001154 acute effect Effects 0.000 description 9
- 210000003414 extremity Anatomy 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 231100000019 skin ulcer Toxicity 0.000 description 9
- 210000002435 tendon Anatomy 0.000 description 9
- 206010010356 Congenital anomaly Diseases 0.000 description 8
- 206010060891 General symptom Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 208000001431 Psychomotor Agitation Diseases 0.000 description 8
- 206010038743 Restlessness Diseases 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 208000001780 epistaxis Diseases 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 230000010354 integration Effects 0.000 description 8
- 230000002147 killing effect Effects 0.000 description 8
- 244000045947 parasite Species 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 206010023126 Jaundice Diseases 0.000 description 7
- 208000019255 Menstrual disease Diseases 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 208000025747 Rheumatic disease Diseases 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 7
- 230000004087 circulation Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 235000008216 herbs Nutrition 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 239000002398 materia medica Substances 0.000 description 7
- 239000002674 ointment Substances 0.000 description 7
- 238000010791 quenching Methods 0.000 description 7
- 230000000552 rheumatic effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 6
- 206010013954 Dysphoria Diseases 0.000 description 6
- 206010014198 Eczema infantile Diseases 0.000 description 6
- 206010043458 Thirst Diseases 0.000 description 6
- 241000223238 Trichophyton Species 0.000 description 6
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 6
- 208000002894 beriberi Diseases 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 230000002950 deficient Effects 0.000 description 6
- 230000006866 deterioration Effects 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000003419 expectorant effect Effects 0.000 description 6
- 230000004438 eyesight Effects 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 230000007803 itching Effects 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 230000003211 malignant effect Effects 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 208000037920 primary disease Diseases 0.000 description 6
- 230000003014 reinforcing effect Effects 0.000 description 6
- 230000002040 relaxant effect Effects 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 206010010726 Conjunctival oedema Diseases 0.000 description 5
- 206010010741 Conjunctivitis Diseases 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 206010062575 Muscle contracture Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 206010033799 Paralysis Diseases 0.000 description 5
- 208000002474 Tinea Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000001166 anti-perspirative effect Effects 0.000 description 5
- 239000003213 antiperspirant Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 208000006111 contracture Diseases 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 230000006735 deficit Effects 0.000 description 5
- 238000007599 discharging Methods 0.000 description 5
- 208000017574 dry cough Diseases 0.000 description 5
- 208000013403 hyperactivity Diseases 0.000 description 5
- 206010022000 influenza Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 206010029410 night sweats Diseases 0.000 description 5
- 230000036565 night sweats Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 210000003800 pharynx Anatomy 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 201000005404 rubella Diseases 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 208000019838 Blood disease Diseases 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 4
- 206010012435 Dermatitis and eczema Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 4
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 4
- 208000019693 Lung disease Diseases 0.000 description 4
- 206010025421 Macule Diseases 0.000 description 4
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 206010039085 Rhinitis allergic Diseases 0.000 description 4
- 206010040844 Skin exfoliation Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 206010048222 Xerosis Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 201000010105 allergic rhinitis Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000001139 anti-pruritic effect Effects 0.000 description 4
- 239000000739 antihistaminic agent Substances 0.000 description 4
- 239000003908 antipruritic agent Substances 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 208000014951 hematologic disease Diseases 0.000 description 4
- 208000018706 hematopoietic system disease Diseases 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 210000003026 hypopharynx Anatomy 0.000 description 4
- 230000000292 leukogenic effect Effects 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 229930014456 matrine Natural products 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 230000000116 mitigating effect Effects 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 229940112824 paste Drugs 0.000 description 4
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000012657 Atopic disease Diseases 0.000 description 3
- 201000009030 Carcinoma Diseases 0.000 description 3
- 206010007882 Cellulitis Diseases 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 201000005505 Measles Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 206010037714 Quadriplegia Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 229940124623 antihistamine drug Drugs 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 206010013023 diphtheria Diseases 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 201000002364 leukopenia Diseases 0.000 description 3
- 231100001022 leukopenia Toxicity 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 201000003453 lung abscess Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000001617 migratory effect Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000001473 noxious effect Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000002048 spasmolytic effect Effects 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 229960001967 tacrolimus Drugs 0.000 description 3
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 208000003014 Bites and Stings Diseases 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 229930194248 Licoflavone Natural products 0.000 description 2
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 244000007703 Mentha citrata Species 0.000 description 2
- 235000007421 Mentha citrata Nutrition 0.000 description 2
- 235000008660 Mentha x piperita subsp citrata Nutrition 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 235000019082 Osmanthus Nutrition 0.000 description 2
- 241000333181 Osmanthus Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 201000004484 acute conjunctivitis Diseases 0.000 description 2
- 231100000293 acute skin toxicity Toxicity 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 201000009961 allergic asthma Diseases 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229960000785 fluocinonide Drugs 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 206010021198 ichthyosis Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 229940105902 mint extract Drugs 0.000 description 2
- 201000002266 mite infestation Diseases 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 229930015582 oxymatrine Natural products 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 235000012950 rattan cane Nutrition 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 201000004700 rosacea Diseases 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002918 waste heat Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 241000331777 Arisaema balansae Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 229940122739 Calcineurin inhibitor Drugs 0.000 description 1
- 101710192106 Calcineurin-binding protein cabin-1 Proteins 0.000 description 1
- 102100024123 Calcineurin-binding protein cabin-1 Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241000253343 Chromadorea Species 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000338702 Cupido minimus Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101150063233 FLG gene Proteins 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000029836 Inguinal Hernia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 208000032923 Lobar pneumonia Diseases 0.000 description 1
- 101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 241000669298 Pseudaulacaspis pentagona Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000007123 Pulmonary Atelectasis Diseases 0.000 description 1
- 206010037868 Rash maculo-papular Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 230000006044 T cell activation Effects 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000013222 Toxemia Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000019667 acute articular rheumatism Diseases 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 201000004559 cerebral degeneration Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 239000005482 chemotactic factor Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 210000004252 chorionic villi Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 208000010932 epithelial neoplasm Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960004189 ethacridine lactate Drugs 0.000 description 1
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Natural products CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 208000012965 maculopapular rash Diseases 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 210000001369 pituitary-adrenal system Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000010181 polygamy Effects 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000022 skin irritation / corrosion Toxicity 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 231100000617 superantigen Toxicity 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000021228 wine soup Nutrition 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 239000009792 yinqiao Substances 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229940052228 zinc oxide paste Drugs 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical compound [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310491169.7A CN103520572B (zh) | 2013-10-18 | 2013-10-18 | 一种用于治疗特应性皮炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310491169.7A CN103520572B (zh) | 2013-10-18 | 2013-10-18 | 一种用于治疗特应性皮炎的中药组合物及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103520572A true CN103520572A (zh) | 2014-01-22 |
| CN103520572B CN103520572B (zh) | 2015-12-23 |
Family
ID=49923159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310491169.7A Expired - Fee Related CN103520572B (zh) | 2013-10-18 | 2013-10-18 | 一种用于治疗特应性皮炎的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103520572B (zh) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103976905A (zh) * | 2014-05-29 | 2014-08-13 | 上海清轩生物科技有限公司 | 一种具有消炎抗过敏作用的植物提取液混合物 |
| CN104055956A (zh) * | 2014-07-08 | 2014-09-24 | 马丽 | 一种治疗皮肤瘙痒症的中药组合物 |
| CN105661664A (zh) * | 2016-01-25 | 2016-06-15 | 邱定武 | 一种治疗痛风的袜底及其制备草药 |
| CN106038813A (zh) * | 2016-06-10 | 2016-10-26 | 周振勇 | 一种治疗玫瑰糠疹的药物 |
| FR3046541A1 (fr) * | 2016-01-12 | 2017-07-14 | Soc Ind Limousine D'application Biologique | Principe actif obtenu a partir d'ophiopogon japonicus pour le traitement de la dermatite atopique |
| CN107582799A (zh) * | 2017-10-27 | 2018-01-16 | 成都中医药大学附属医院 | 一种治疗特应性皮炎的药物组合物及其制备方法和用途 |
| CN108434242A (zh) * | 2018-06-22 | 2018-08-24 | 中南民族大学 | 一种用于治疗糖尿病及其并发症的药物组合物、制备方法及其用途 |
| EP3508210A4 (en) * | 2016-09-01 | 2020-06-10 | University - Industry Cooperation Group of Kyung Hee University | COMPOSITION WITH AN EXTRACT FROM A VEGETABLE MEDICAL MIXTURE FOR THE TREATMENT OF ATOPIC DERMATITIS |
| CN116270809A (zh) * | 2023-04-04 | 2023-06-23 | 中国中医科学院西苑医院 | 治疗特应性皮炎的中药复方安神止痒健脾方及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129577A (zh) * | 1995-09-15 | 1996-08-28 | 贾阳春 | 普癣丸(块) |
| CN1214261A (zh) * | 1998-10-21 | 1999-04-21 | 余际康 | 一种治疗皮肤病的口服药 |
| CN102416127A (zh) * | 2011-12-09 | 2012-04-18 | 崔国志 | 一种治疗牛皮癣的中药散剂 |
-
2013
- 2013-10-18 CN CN201310491169.7A patent/CN103520572B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129577A (zh) * | 1995-09-15 | 1996-08-28 | 贾阳春 | 普癣丸(块) |
| CN1214261A (zh) * | 1998-10-21 | 1999-04-21 | 余际康 | 一种治疗皮肤病的口服药 |
| CN102416127A (zh) * | 2011-12-09 | 2012-04-18 | 崔国志 | 一种治疗牛皮癣的中药散剂 |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103976905A (zh) * | 2014-05-29 | 2014-08-13 | 上海清轩生物科技有限公司 | 一种具有消炎抗过敏作用的植物提取液混合物 |
| CN104055956A (zh) * | 2014-07-08 | 2014-09-24 | 马丽 | 一种治疗皮肤瘙痒症的中药组合物 |
| US11311596B2 (en) | 2016-01-12 | 2022-04-26 | Societe Industrielle Limousine D'application Biologique | Active ingredient obtained from Ophiopogon japonicus for the treatment of atopic dermatitis |
| FR3046541A1 (fr) * | 2016-01-12 | 2017-07-14 | Soc Ind Limousine D'application Biologique | Principe actif obtenu a partir d'ophiopogon japonicus pour le traitement de la dermatite atopique |
| WO2017121965A1 (fr) * | 2016-01-12 | 2017-07-20 | Societe Industrielle Limousine D'application Biologique | Principe actif obtenu a partir d'ophiopogon japonicus pour le traitement de la dermatite atopique |
| CN105661664A (zh) * | 2016-01-25 | 2016-06-15 | 邱定武 | 一种治疗痛风的袜底及其制备草药 |
| CN105661664B (zh) * | 2016-01-25 | 2017-08-01 | 邱定武 | 一种治疗痛风的袜底及其制备草药 |
| CN106038813A (zh) * | 2016-06-10 | 2016-10-26 | 周振勇 | 一种治疗玫瑰糠疹的药物 |
| EP3508210A4 (en) * | 2016-09-01 | 2020-06-10 | University - Industry Cooperation Group of Kyung Hee University | COMPOSITION WITH AN EXTRACT FROM A VEGETABLE MEDICAL MIXTURE FOR THE TREATMENT OF ATOPIC DERMATITIS |
| US11666619B2 (en) | 2016-09-01 | 2023-06-06 | K-Lab Corp. | Composition for treating atopic dermatitis including herbal medicine mixed extract |
| CN107582799A (zh) * | 2017-10-27 | 2018-01-16 | 成都中医药大学附属医院 | 一种治疗特应性皮炎的药物组合物及其制备方法和用途 |
| CN108434242A (zh) * | 2018-06-22 | 2018-08-24 | 中南民族大学 | 一种用于治疗糖尿病及其并发症的药物组合物、制备方法及其用途 |
| CN116270809A (zh) * | 2023-04-04 | 2023-06-23 | 中国中医科学院西苑医院 | 治疗特应性皮炎的中药复方安神止痒健脾方及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103520572B (zh) | 2015-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN102145064B (zh) | 一种治疗老年性阴道炎的中药组合物及其制备方法 | |
| CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
| CN102755596B (zh) | 一种治疗痰湿型乳腺增生的中药及制备方法 | |
| CN102166278B (zh) | 一种治疗小儿类风湿性关节炎的中药组合物及其制备方法 | |
| CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
| CN102000164B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
| CN103041208A (zh) | 一种治疗妇女更年期综合征的中药制剂及其制备方法 | |
| CN104958607A (zh) | 一种治疗妇女更年期灼口综合征的中药组合物及方法 | |
| CN104689226A (zh) | 一种治疗小儿类风湿性关节炎的中药组合物及其制备方法 | |
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN104474500A (zh) | 一种补血调经的中药保健品及其制备方法 | |
| CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
| CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
| CN102846824B (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
| CN104740583A (zh) | 一种用于缓解克罗恩病的中药制剂及其制备方法 | |
| CN104815037A (zh) | 一种治疗风湿蕴毒型慢性湿疹的药物及其制备方法 | |
| CN104147538A (zh) | 一种治疗湿热毒盛型糖尿病足的中药制剂及其制备方法 | |
| CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
| CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
| CN104906430A (zh) | 一种治疗干眼症的中药制剂及其制备方法 | |
| CN104815232A (zh) | 一种治疗原发性肺动脉高压的中药制剂及其制备方法 | |
| CN103656048A (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
| CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
| CN104825892B (zh) | 一种治疗排卵期出血的中药制剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhou Bopeng Inventor before: Li Dianchang Inventor before: Liang Diecong |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20151118 Address after: 262409 Shandong city of Weifang province Changle County resident town government Tang a surname Applicant after: Li Tianchang Address before: Shinan District 266073 Shandong city of Qingdao province No. 7 Yinchuan West Road, Yinhai No. 1 7-2-505 Applicant before: Li Dianchang |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151223 Termination date: 20161018 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |